| AMY | Amylase |
| AUC | Area under curve |
| BMI | Body mass index |
| CA | Carbohydrate antigen |
| CT | Computed tomography |
| DCA | Decision curve analysis |
| DNA | Deoxyribonucleic acid |
| EGFR | Epidermal growth factor receptor |
| FPR | False positive rate |
| GA | Glycated albumin |
| GGO | Ground-glass opacity |
| HBsAb | Hepatitis B surface antibody |
| ICI | Immune checkpoint inhibitors |
| LASSO | Least absolute shrinkage and selection operator |
| LDL-C | Low-density lipoprotein cholesterol |
| LUAD | Lung adenocarcinoma |
| MAP | Mean arterial pressure |
| MCV | Mean corpusular volume |
| Mg | Magnesium |
| NGS | Next-generation sequencing |
| NSCLC | Non-small cell lung cancer |
| NSE | Neuron specific enolase |
| OS | Overall survival |
| PCT | Plateletocrit |
| PD-1 | Programed death-1 |
| PLT | Platelet count |
| PN | Pulmonary nodule |
| RBC | Red blood cell |
| RDW | Red cell volume distribution width |
| ROC | Receiver operating characteristic curve |
| ROI | Region of interest |
| sMPLC | Synchronous multiple primary lung cancer |
| SABR | Stereotactic ablative radiotherapy |
| TBiL | Total bilirubin |
| TKI | Tyrosine kinase inhibitors |
| TMB | Tumor mutation burden |
| TPR | True positive rate |
| TT | Thrombin time |
| UGA | Urine glucaric acid |
| UALB | Urinary albumin |